Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Alkermes plc (ALKS)

-NasdaqGS
46.21 Up 0.79(1.74%) 4:00PM EDT
Prev Close:45.42
Open:45.62
Bid:45.53 x 100
Ask:N/A
1y Target Est:50.92
Beta:1.5
Next Earnings Date:N/A
Day's Range:45.41 - 46.44
52wk Range:28.86 - 54.25
Volume:527,399
Avg Vol (3m):791,389
Market Cap:6.68B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 1.74%6.68B
ABTDown 0.28%64.54B
LLYUp 0.83%68.92B
GSKDown 5.98%120.45B

Key Statistics

Forward P/E (1 yr):66.97
P/S (ttm):12.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.49
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback